- Home
- MRNA vs SEIC Comparison
MRNA vs SEIC Comparison
Compare MRNA & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- SEIC
- Stock Information
- Founded
- MRNA 2010
- SEIC 1968
- Country
- MRNA United States
- SEIC United States
- Employees
- MRNA N/A
- SEIC N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- SEIC Investment Bankers/Brokers/Service
- Sector
- MRNA Health Care
- SEIC Finance
- Exchange
- MRNA Nasdaq
- SEIC Nasdaq
- Market Cap
- MRNA 9.2B
- SEIC 10.2B
- IPO Year
- MRNA 2018
- SEIC N/A
- Fundamental
- Price
- MRNA $26.33
- SEIC $83.60
- Analyst Decision
- MRNA Hold
- SEIC Buy
- Analyst Count
- MRNA 15
- SEIC 7
- Target Price
- MRNA $36.69
- SEIC $100.29
- AVG Volume (30 Days)
- MRNA 12.0M
- SEIC 646.0K
- Earning Date
- MRNA 11-06-2025
- SEIC 10-22-2025
- Dividend Yield
- MRNA N/A
- SEIC 1.17%
- EPS Growth
- MRNA N/A
- SEIC 30.71
- EPS
- MRNA N/A
- SEIC 5.43
- Revenue
- MRNA $2,232,000,000.00
- SEIC $2,246,646,000.00
- Revenue This Year
- MRNA N/A
- SEIC $9.87
- Revenue Next Year
- MRNA $10.38
- SEIC $8.01
- P/E Ratio
- MRNA N/A
- SEIC $15.44
- Revenue Growth
- MRNA N/A
- SEIC 9.44
- 52 Week Low
- MRNA $23.04
- SEIC $64.66
- 52 Week High
- MRNA $48.92
- SEIC $93.96
- Technical
- Relative Strength Index (RSI)
- MRNA 53.21
- SEIC 54.98
- Support Level
- MRNA $23.04
- SEIC $80.59
- Resistance Level
- MRNA $25.56
- SEIC $82.84
- Average True Range (ATR)
- MRNA 1.58
- SEIC 1.48
- MACD
- MRNA -0.07
- SEIC 0.41
- Stochastic Oscillator
- MRNA 57.39
- SEIC 88.39
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $87 billion in assets under management. As of December 2024, SEI (including LSV) manages, administers, or advises about $1.6 trillion in assets.